Crown Castle Names Sunit Patel as Chief Financial Officer
HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today the appointment of Sunit Patel to the position of Executive Vice President and Chief…
HighCo: Agreement to sell High Connexion
Aix-en-Provence, 19 March 2025 (7 p.m.) HIGHCO SIGNS AN AGREEMENT TO SELL ITS SUBSIDIARY HIGH CONNEXION HighCo announces that it has entered into an agreement, subject to conditions precedent, to…
Leslie’s, Inc. Announces Executive Leadership Changes
Appoints Tony Iskander as Interim Chief Financial Officer and TreasurerPromotes Naomi Cramer to Chief Retail Operations and Talent Officer PHOENIX, March 17, 2025 (GLOBE NEWSWIRE) -- Leslie’s, Inc. (“Leslie’s”, “we”,…
Crown Castle Appoints Katherine Motlagh to its Board of Directors
HOUSTON, March 17, 2025 (GLOBE NEWSWIRE) -- Crown Castle Inc. (NYSE: CCI) ("Crown Castle") announced today the appointment of Katherine Motlagh to its board of directors. Ms. Motlagh’s appointment is…
Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements
– Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to robust long-term clinical responses and was well tolerated; Phase…
Home BancShares, Inc. Announces First Quarter Earnings Release Date and Conference Call
CONWAY, Ark., March 17, 2025 (GLOBE NEWSWIRE) -- Home BancShares, Inc. (NYSE: HOMB), parent company of Centennial Bank, today announced it expects to release First Quarter 2025 earnings after the…
EZCORP Announces Termination of Acquisition Agreement
AUSTIN, Texas, March 19, 2025 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) (the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today that…
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International.…
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ~10‑million‑patient marketAcquisition advances Paratek’s vision to become a multi-product…
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market
Arcadis acquires WSP Infrastructure Engineering GmbH, strengthening its position in the attractive German rail market Amsterdam, 20 March 2025 – Arcadis, a global leader in intelligence-driven sustainable design, engineering, and…